home

Highly read articles on psoriatic arthritis highlight biologics news

CommentsHEALIO2016-04-14 14:13 Read   114

Biologics, and particularly biosimilars, have been in the news about psoriatic arthritis and other rheumatic, dermatologic and gastrological diseases.

One year after universal HCV treatment, Portugal shows 96% SVR rate

CommentsHEALIO2016-04-14 14:07 Read   96

A year after the Portuguese government approved oral treatment for hepatitis C virus for all infected patients, a presenter here showed the country achieved a 96% sustained virologic response rate.

Obesity fuelling leap in womb cancer cases

HealthPHARMATIME2016-04-14 14:01 Read   62

Rising levels of obesity among UK women have helped drive a 54 percent jump in womb cancer rates over the last two decades, according to new figures released by Cancer Research UK.  

Boehringer's Giotrif beats AZ' Iressa in lung cancer trial

Trendpharmatimes2016-04-14 13:55 Read   81

Boehringer Ingelheim’s Giotrif has beaten AstraZeneca’s Iressa on a number of clinical measures investigated in a head-to-head study involving patients with EGFR mutation-positive advanced non-small cell lung cancer.

FDA finds Epigenomics appealing

TrendEP WANTAGE2016-04-14 13:48 Read   70

In pulling off the almost unheard-of feat of successfully appealing against an FDA rejection, Epigenomics today got full approval for its twice-denied colon cancer blood test, saw its share price rise 24%, and shone a light on some rather odd behaviour from the US regulator.

With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets

R&Dxconomy2016-04-14 13:43 Read   72

Harvard University chemical biologist and serial entrepreneur Greg Verdine has spent more than a decade trying to come up with different solutions for one critical problem in biotech: The majority of would-be drug targets are out of reach of existing technologies.

Pharma Nabs $68M, Crossover Backers for Eye Drug Push

R&Dxconomy2016-04-14 13:38 Read   77

It’s been a common sight over the past few years for a biotech startup to bring a bunch of “crossover” investors—who invest in both public and private companies—into the mix before taking a crack at an IPO.

EnsoData Raises $550K to Develop Software That Analyzes Sleep Data

EVENTSxconomy2016-04-14 13:34 Read   49

At an event last August featuring pitches from startups, EnsoData co-founder Chris Fernandez told audience members that his company was hoping to raise $300,000 in a seed funding round.

ASCO pushes more HPV vaccine use in published recommendations

Commentsfiercepharma2016-04-14 13:25 Read   66

Calling the situation "alarming," all 69 of the NCI-designated cancer centers in February joined together to warn about the severely low rate of HPV vaccination in the United States.

Worldwide switch to bivalent oral polio vaccine to kick off on Sunday

Healthfiercepharma2016-04-14 13:21 Read   57

The trivalent vaccine protects against poliovirus types 1, 2 and 3, but type 2 was declared eradicated in 1999.

Pharma primed to invest in services, but will patients get the message?

Frontierfiercepharma2016-04-14 13:17 Read   68

Patient services are no longer an add-on but a must-have. That's one of the conclusions in a new report from Accenture ($ACN)--one that also finds that pharma companies are putting their money in the game.

Valeant CEO Pearson bows to Senate committee after public scolding

EVENTSfiercepharma2016-04-14 13:08 Read   54

Valeant Pharmaceuticals' ($VRX) public reprimand must have worked. After balking at the idea last week, CEO Michael Pearson agreed to give a deposition to the Senate Special Committee on Aging.